Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Clin Cancer Res. 2021 Oct 1;27(19):5353–5364. doi: 10.1158/1078-0432.CCR-20-4641

Figure 2. In vivo PET imaging with diminished abdominal uptake in animals that received dexamethasone.

Figure 2.

A) Representative PET/CT MIP images at 1 hour post-injection of 68Ga-NOTA-GZP of animals injected with immunotherapy and immunotherapy + dexamethasone. B) ROI analysis of blood pool and major organs, represented as %ID/g. *p = 0.01, ** p < 0.01, **** p < 0.0001